Aberdeen Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-73,470
Closed -$739K 904
2023
Q2
$739K Sell
73,470
-73,177
-50% -$679K ﹤0.01% 811
2023
Q1
$1.38M Buy
146,647
+44,369
+43% +$523K ﹤0.01% 765
2022
Q4
$1.25M Buy
102,278
+7,595
+8% +$94.7K ﹤0.01% 752
2022
Q3
$1.18M Buy
94,683
+39,647
+72% +$693K ﹤0.01% 766
2022
Q2
$1.1M Buy
55,036
+3,161
+6% +$74.8K ﹤0.01% 775
2022
Q1
$1.39M Sell
51,875
-10,509
-17% -$280K ﹤0.01% 786
2021
Q4
$1.77M Buy
62,384
+5,717
+10% +$178K ﹤0.01% 799
2021
Q3
$1.83M Buy
56,667
+8,675
+18% +$291K ﹤0.01% 798
2021
Q2
$1.67M Sell
47,992
-3,158
-6% -$104K ﹤0.01% 803
2021
Q1
$1.51M Buy
51,150
+6,201
+14% +$191K ﹤0.01% 808
2020
Q4
$1.38M Buy
44,949
+4,368
+11% +$133K ﹤0.01% 799
2020
Q3
$1.13M Sell
40,581
-11,545
-22% -$293K ﹤0.01% 783
2020
Q2
$1.12M Buy
52,126
+2,499
+5% +$55.2K ﹤0.01% 769
2020
Q1
$1.11M Buy
49,627
+565
+1% +$15.5K ﹤0.01% 751
2019
Q4
$1.45M Buy
49,062
+5,044
+11% +$137K ﹤0.01% 757
2019
Q3
$1.17M Buy
44,018
+2,346
+6% +$70.4K ﹤0.01% 779
2019
Q2
$1.41M Buy
41,672
+3,124
+8% +$101K ﹤0.01% 787
2019
Q1
$1.24M Buy
+38,548
New +$1.19M ﹤0.01% 786

Other funds holding ELAN

Aberdeen Group's ELAN Position: Q3 2023 in Review

Aberdeen Group sold out of Elanco Animal Health (ELAN) in Q3 2023, closing a stake of 73,470 shares — an estimated $739K sold.

Aberdeen Group first reported a position in ELAN in Q1 2019 and held it in 18 quarters. The position peaked at $1.83M in Q3 2021. 350 funds tracked by Wall St. Rank hold ELAN as of Q3 2023.

  • Aberdeen Group reported no remaining Elanco Animal Health position as of Q3 2023 after selling out during the quarter.
  • Aberdeen Group sold 73,470 Elanco Animal Health shares in Q3 2023, an estimated $739K.
  • Aberdeen Group first reported a position in Elanco Animal Health in Q1 2019 and held it in 18 quarters.
  • Aberdeen Group's Elanco Animal Health position peaked at $1.83M in Q3 2021.
  • 350 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2023.

Based on Aberdeen Group's 13F filing for Q3 2023, filed 7 Nov 2023.